Adjunct Research Fellow

Martin is a Medicinal and Organic Chemist, specialising in computer-aided drug design and has 34 years’ experience in inflammatory disease and infectious diseases research. His antiviral research interests started with HIV and progressed to proteases from Flaviviruses and Coronaviruses, specifically Dengue and West Nile Viruses, and COVID-19. Molecular targets of his anti-inflammatory work include human G Protein-Coupled Receptors C3aR, C5aR, PAR2 and phospholipases.

 

Martin completed his Ph.D. in organic and organometallic chemistry at the University of Sydney in 1990, followed by postdoctoral appointments at Bond University, the University of Queensland, Technische Universität, Clausthal-Zellerfeld, Germany, Victorian College of Pharmacy, Monash University (now MIPS), before returning to the Institute for Molecular Bioscience, University of Queensland in 2000. Since 2018 he has been an adjunct Research Fellow at IMB looking into the molecular diversity in Flaviviral and Coronaviral proteases as predictors of future pandemic or emerging epidemic viruses.